AtriCure Inc. operates as a medical device company that develops, manufactures and sells innovative solutions designed to decrease the global atrial fibrillation (AFib) epidemic. AtriCure’s primary products work to treat AFib, a heart disorder, and associated conditions across the globe.
AtriCure can be found operating within the healthcare sector and plays a critical role in providing vital health solutions. AtriCure’s flagship product line consists of both ablation and left atrial appendage management tools.
Stay up to date on the share price of ATRC by adding it to your eToro watchlist.